FDA Inspection
Claire L. Keating, M.D.Claire L. Keating, M.D. – FDA Inspection, Sep 29, 2017
Record Details
This FDA Inspection record concerns Claire L. Keating, M.D., with an inspection on September 29, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5debdf9f-64d8-411e-bb7d-3371973bdebd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1027367
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Claire L. Keating, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 16, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Claire L. Keating, M.D.
- FDA Inspection 1248575 - 2024-08-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.